Uncategorized

The patent dispute over pulse oximetry functions could result in a ban on imports of some Apple Watches.

Nearly 94% of patients had their condition improve to mild or no tricuspid regurgitation six months after treatment, according to the study.

On average, organizations were shut down or unavailable to provide services for 14 days to due to ransomware attacks from 2016 through mid-October this year, according to cybersecurity research firm Comparitech.

The Health Resources and Services Administration is once again requiring hospitals to register outpatient clinics and list them on Medicare cost reports, setting a higher bar for eligibility in the drug discount program.

The company’s group president for medical products and therapies says the right fluid management practices can help save lives and lower hospital costs.

The company delivered fourth quarter results that fell short of analyst expectations in August, causing its share price to fall.

Even if modestly accretive, AI could support longer-term revenue targets at GE HealthCare and its competitors, Moody’s analysts wrote.

ImmunoGen, Inc. announced that the European Medicines Agency has accepted the Marketing Authorization Application for mirvetuximab soravtansine for the treatment of patients with folate receptor alpha -positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Atamyo Therapeutics announced the presentation of the first clinical results obtained with ATA-100 in the on-going ATA-001 Phase 1b/2b clinical trial.

Innate Pharma SA announced that members of its senior management team are scheduled to participate in upcoming investor conferences, detailed below.